Pediatric Long-Term Follow-up and Rollover Study
Conditions
Diffuse Astrocytoma · Anaplastic Astrocytoma · Astrocytoma · Oligodendroglioma, Childhood · Anaplastic Oligodendroglioma · Glioblastoma · Pilocytic Astrocytoma · Giant Cell Astrocytoma · Pleomorphic Xanthoastrocytoma · Anaplastic Pleomorphic Xanthoastrocytoma · Angiocentric Glioma · Chordoid Glioma of Third Ventricle · Gangliocytoma · Ganglioglioma · Anaplastic Ganglioglioma · Dysplastic Gangliocytoma of Cerebrellum · Desmoplastic Infantile Astrocytoma and Ganglioglioma · Papillary Glioneuronal Tumor · Rosette-forming Glioneuronal Tumor · Central Neurocytoma · Extraventricular Neurocytoma · Cerebellar Liponeurocytoma · Neurofibromatosis Type 1
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Phoenix Children s Hospital, Phoenix, Arizona, United States
Childrens National Hospital, Washington D.C., District of Columbia, United States
Nicklaus Childrens Hospital, Miami, Florida, United States
Indiana Uni School of Medicine, Indianapolis, Indiana, United States
Johns Hopkins Hospital, Baltimore, Maryland, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
University of Minnesota, Minneapolis, Minnesota, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Principal Investigator (Stephen Gilheeney)Memorial Sloan Kettering Cancer Ctr, New York, New York, United States
Cinn Children Hosp Medical Center, Cincinnati, Ohio, United States
St Jude Childrens Research Hospital, Memphis, Tennessee, United States
Texas Childrens Hospital, Houston, Texas, United States
Novartis Investigative Site, CABA, Buenos Aires, Argentina
Novartis Investigative Site, Darlinghurst, New South Wales, Australia
Novartis Investigative Site, Parkville, Victoria, Australia
Novartis Investigative Site, Brussels, Belgium
Novartis Investigative Site, Barretos, São Paulo, Brazil
Novartis Investigative Site, São Paulo, São Paulo, Brazil
Novartis Investigative Site, São Paulo, São Paulo, Brazil
Novartis Investigative Site, Vancouver, British Columbia, Canada
Novartis Investigative Site, Toronto, Ontario, Canada
Novartis Investigative Site, Montreal, Quebec, Canada
Novartis Investigative Site, Brno, Czechia
Novartis Investigative Site, Prague, Czechia
Novartis Investigative Site, Copenhagen, Denmark
Novartis Investigative Site, Tampere, Finland
Novartis Investigative Site, Rennes, Brittany Region, France
Novartis Investigative Site, Brest, France
Novartis Investigative Site, Marseille, France
Novartis Investigative Site, Paris, France
Novartis Investigative Site, Rennes, France
Novartis Investigative Site, Vandœuvre-lès-Nancy, France
Novartis Investigative Site, Villejuif, France
Novartis Investigative Site, Cologne, North Rhine-Westphalia, Germany
Novartis Investigative Site, Augsburg, Germany
Novartis Investigative Site, Berlin, Germany
Novartis Investigative Site, Essen, Germany
Novartis Investigative Site, Hamburg, Germany
Novartis Investigative Site, Petah Tikva, Israel
Novartis Investigative Site, Florence, FI, Italy
Novartis Investigative Site, Genova, GE, Italy
Novartis Investigative Site, Milan, MI, Italy
Novartis Investigative Site, Roma, RM, Italy
Novartis Investigative Site, Torino, TO, Italy
Novartis Investigative Site, Setagaya-ku, Tokyo, Japan
Novartis Investigative Site, Osaka, Japan
Novartis Investigative Site, Utrecht, Netherlands
Novartis Investigative Site, Moscow, Russia
Novartis Investigative Site, Madrid, Spain
Novartis Investigative Site, Valencia, Spain
Novartis Investigative Site, Stockholm, Sweden
Novartis Investigative Site, Sutton, Surrey, United Kingdom
Novartis Investigative Site, Liverpool, United Kingdom
Novartis Investigative Site, London, United Kingdom
Novartis Investigative Site, London, United Kingdom
Study leads
Novartis Pharmaceuticals
Study Director
Novartis Pharmaceuticals